Statins in heart failure: The paradox between large randomized clinical trials and real life

Mayo Clinic Proceedings

Volumn 87, Issue 6, 2012, Pages 555-560

  Gastelurrutia, Paloma ^a   Lupón, Josep ^b,c   De Antonio, Marta ^b   Urrutia, Agustin ^b,c   Díez, Crisanto ^b,c   Coll, Ramón ^b,c   Altimir, Salvador ^b,c   Bayes Genis, Antoni ^b,c  

^a Germans Trias i Pujol Research Institute in Health Sciences   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL; TREATMENT OUTCOME;

EID: 84863474472     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2012.02.018     Document Type: Conference Paper

References (21)

1. Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol. 2006;47(2):332-337. (Pubitemid 43063250)
2. Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation. 2003;108(7):839-843. (Pubitemid 37022126)
3. Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol. 2004;93(9):1124-1129. (Pubitemid 38521041)
4. Horwich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol. 2004;43(4):642-648. (Pubitemid 38229538)
5. Krum H, Latini R, Maggioni AP, et al. Statins and symptomatic chronic systolic heart failure: A post-hoc analysis of 5010 patients enrolled in Val-HeFT. Int J Cardiol. 2007;119(1):48-53. (Pubitemid 46830817)
6. Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006;296(17):2105- 2111. (Pubitemid 44664705)
7. GISSI-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1231-1239.
8. Kjekshus J, Apetrei E, Barrios V, et al; CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357(22):2248- 2261. (Pubitemid 350190755)
9. Lavie CJ, Mehra MR. Statins and advanced heart failure-alive but barely breathing after CORONA and GISSI-HF. Congest Heart Fail. 2009;15(4):157-158.
10. Sumner AD, Boehmer JP, Saxon LA, et al. Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy. Congest Heart Fail. 2009;15(4):159-164.
11. Masoudi FA. Statins for ischemic systolic heart failure. N Engl J Med. 2007;357(22):2301-2304. (Pubitemid 350190763)
12. Khush KK, Waters DD, Bittner V, et al. Effect of high-dose atorvastatin on hospitalizations for heart failure: Subgroup analysis of the Treating to New Targets (TNT) study. Circulation. 2007;115(5):576-583. (Pubitemid 46226167)
13. Nezasa K, Higaki K, Matsumura T, et al. Liver-specific distribution of rosuvastatin in rats: Comparison with pravastatin and simvastatin. Drug Metab Dispos. 2002;30(11):1158-1163. (Pubitemid 35265820)
14. White CM. A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin. J Clin Pharmacol. 2002;42(9):963-970. (Pubitemid 34920793)
15. Lipinski MJ, Cauthen C, Biondi-Zoccai GL, et al. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure. Am J Cardiol. 2009;104(12):1708-1716.
16. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383-1389.
17. Daniels LB, Barrett-Connor E. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial? J Am Coll Cardiol. 2009;54(20):1860-1861.
18. Cleland JG, McMurray JJ, Kjekshus J, et al. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: Prediction of cardiovascular events and interaction with the effects of rosuvastatin: A report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol. 2009;54(20):1850-1859.
19. Athyros VG, Karagiannis A, Mikhailidis DP. Statins and heart failure. J Am Coll Cardiol. 2010;55(15):1644-1645.
20. Sever PS, Chang CL, Gupta AK, Whitehouse A, Poulter NR; ASCOT Investigators. The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K. Eur Heart J. 2011;32(20):2525-2532.
21. Tleyjeh IM, Kashour T, Hakim FA, et al. Statins for the prevention and treatment of infections: A systematic review and meta-analysis [published correction appears in Arch Intern Med 2010;170(1):42]. Arch Intern Med. 2009;169(18):1658-1667.